Phytochemical Screening and Antimicrobial Study on Euphorbia Hirta Plant Extracts

The present study demonstrates that Euphorbia hirta contains a wide array of pharmacologically important secondary metabolites, and its extracts – particularly the ethanolic extract – possess significant antimicrobial activity against common bacterial and fungal pathogens. These findings lend scientific support to the traditional use of Euphorbia hirta in the management of infectious conditions and suggest its potential as a source for the development of new, plant-derived antimicrobial agents. Further studies involving isolation and characterization of the active constituents, along with in-vivo evaluation and toxicity studies, are recommended to fully establish its therapeutic potential.

[1] Kokate C.K., Purohit A.P., Gokhale S.B., “Pharmacognosy,” Nirali Prakashan, Pune, 50th ed., 2016. [2] Khandelwal K.R., “Practical Pharmacognosy – Techniques and Experiments,” Nirali Prakashan, Pune, 29th ed., 2019. [3] Kirtikar K.R., Basu B.D., “Indian Medicinal Plants,” International Book Distributors, Dehradun, 2nd ed., Vol. 3, 1991. [4] Ogueke C.C., Ogbulie J.N., Okoli I.C., Anyanwu B.N., “Antibacterial activities and toxicological potentials of crude ethanolic extracts of Euphorbia hirta,” Journal of American Science, vol. 3, no. 3, pp. 11–16, 2007. [5] Ogbulie J.N., Ogueke C.C., Okoli I.C., Anyanwu B.N., “Antibacterial activities and toxicological potentials of crude ethanolic extracts of Euphorbia hirta,” African Journal of Biotechnology, vol. 6, no. 13, pp. 1544–1548, 2007. [6] Sharma N., Samarakoon K.W., Gyawali R., et al., “Evaluation of the antimicrobial, antioxidant and anti-inflammatory activity of Euphorbia hirta,” Plants, vol. 3, pp. 380–393, 2014. [7] Perumal Samy R., Ignacimuthu S., Sen A., “Screening of 34 Indian medicinal plants for antibacterial properties,” Journal of Ethnopharmacology, vol. 62, pp. 173–182, 1998. [8] Harborne J.B., “Phytochemical Methods – A Guide to Modern Techniques of Plant Analysis,” Chapman & Hall, London, 3rd ed., 1998. [9] Trease G.E., Evans W.C., “Pharmacognosy,” W.B. Saunders, London, 15th ed., 2002. [10] CLSI, “Performance Standards for Antimicrobial Disk Susceptibility Tests,” Clinical and Laboratory Standards Institute, Wayne, PA, 13th ed., 2018.